Nektar Therapeutics | NKTR - Interest Income


Nektar Therapeutics reported $-0.18 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 10.8M 1.62M Mar/2026
ALKERMES USD 8.54M 3.59M Mar/2026
Baxter International USD 12M 1000K Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 37.9M 700K Mar/2026
Cara Therapeutics USD 347K 74K Mar/2025
Dr.Reddys Laboratories INR 999M 203M Jun/2026
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Exelixis USD 14.21M 1.92M Jun/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 35M 34M Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD -0.04 115M Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Takeda JPY 24.61B 213.76B Jun/2026
Xencor USD 5.46M 741K Mar/2026